Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01191892
Recruitment Status : Unknown
Verified July 2012 by Wales Cancer Trials Unit.
Recruitment status was:  Recruiting
First Posted : August 31, 2010
Last Update Posted : July 31, 2012
Cardiff University
Information provided by (Responsible Party):
Wales Cancer Trials Unit

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2013
  Estimated Study Completion Date : December 2014